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ABSTRACT OF THESIS 
"The Effects of Aerosolized Lead 
on the Hematopoietic and Imnrune Systems" 
The immunological responsiveness of two groups of mice exposed to 
2.5 mg/m3 aerosolized Pb(N03)2 either since birth or for 14 days prior 
to immunization were compared with mice receiving equivalent quan-
tities Pb(N03)2 (125 ~g/mouse/day) by gastric intubation for 1~ days. 
Each group was immunized at 5 weeks of age with 108 sheep red blood 
cells to examine both primary and secondary antibody responses. Lead 
immunotoxicity was evaluated by comparing total and differential 
leukocyte counts, cellulose acetate electrophoretic serum profiles, 
phagocytic index, hemolytic complement activity, hemagglutination 
antibody titers and organ (lung, thyr.~~us, spleen, kidney and liver) to 
body weight ratios. Atomic absorption spectrophotometry was used to 
determine the concentration of lead in serum, blood and tissues. None 
of the immunological parameters examined were significantly affected 
by lead ingestion. However, aerosolized lead resulted in significant 
decreases in antibody titers; hemolytic complement activity; phago-
cytic indices; thymus to body and spleen to body weight ratios; and 
reduced numbers of monocytes as well as a neutrophilic shift to 
lymphocytes. Effects were greatest in mice born and reared in the 
aerosolization chamber. These results indicate the greater immuno-
toxicity of aerosolized lead compared with ingested lead and thus the 
daily health hazard aerosolized lead presents. 
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PROPOSED RESEARCH METHODS 
The goal of this research -.;-ras to compare the chronic immunological 
effects of aerosolized lead with that of injested lead. 
An outbred strain of Swiss Webster mice originally obtained from 
Charles River Laboratories was used throughout this project. Each 
litter was sexed, distributed equally among groups, and cross-
fostered. The effects of chronic aerosolized lead exposure were 
determined using mice exposed either for 14 days or since birth to 
aerosolized lead in an aerosolization chamber. Mice which received 
orally administered lead received an equivalent amount of lead by 
gastric intubation for 14 days. Both groups of mice had separate 
control groups. Since the immune and hematopoietic systems are 
extremely sensitive to chemical toxi.city, immunological alteration was 
deemed to be an effective means of measuring the potential pollutant 
health hazards caused by lead. 
The parameters used to determine iummunological effects included: 
1) total and differential leucocyte counts; 2) hematocrit values; 
3) serum profile determinations using cellulose acetate electrophor-
esis; 4) antibody levels produced against sheep red blood cells; 
5) measurement of hemolytic complement activity; 6) LDso determina-
tions after intraperitoneal challenge with Salmonella typhimurium; 
7) phagocytic indices of both alveolar and peritoneal macrophage; 
8) liver, lung, thymus, spleen and kidney to body weight ratios; and 
9) atomic absorption spectrophotonetric determinations of the lead 
concentrations in the above mentioned organs. 
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OBJECTIVES 
The objective of this study was to assess the potential immune-
toxic effects of aerosolized lead. This research compared the chronic 
immunological effects of aerosolized lead with that of ingested lead 
and determined that aerosolized lead at a subclinical level has a more 
deleterious effect on both the immune system and the hematopoietic 
system than does ingested lead. 
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STATE~ffiNT OF SIGNIFICANCE 
Lead is a stable chemical element yet it is one of the most insi-
diously toxic metals known to man. The cumulative biological effects 
of environmental lead pollution present a significant hazard to all 
aspects of life. This danger should be a concern for the health 
scientist and the environmentalist, as well as for the agriculturist 
and urban dweller. 
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There are two natural pathways for lead to enter the body, inhala-
tion and ingestion. Aerosolized lead is mobilized into the atmosphere 
as a result of the high temperature combustion of fossil fuels and 
exists largely as inorganic lead particles of variable size. Some of 
these particles are small enough to allow for deep penetration into 
the pulmonary system while the larger particles are cleared by pulmo-
nary cilia and ultimately swallowed. Lead ingestion can occur during 
the consumption of tinned foods or grains and dairy products con-
taminated with urban dusts. 
The major emphasis of previous lead toxicity studies dealt with 
the effects of maternal lead ingestion on fetal development and the 
effects of ingested lead on children. These investigations dealt with 
extreme lead toxicity resulting in miscarriages and neurological 
problems caused by high doses of lead. Only recently have the more 
subtle changes caused by low levels of lead concentration been 
investigated. 
Since the immune system is very sensitive to environmental 
pollutants, it provides an excellent means by which to study the 
effects of subclinical lead intoxication. 
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INTRODUCTION 
The toxicity caused by ingestion of lead has heen a concern for 
man throughout history. Only recently with the introduction of the 
industrial revolution has the need arisen to monitor the effects of 
subclinical lead exposure on human health. 
Recent investigations on the subtle effects of subclinical lead 
toxicity have revealed ultra-structural changes such as the formation 
' of inclusion bodies and metabolic changes such as reduced respiratory 
ability and inhibition of enzymatic activity. The ability of lead to 
mimic the metabolism of calcium can interfer with skeletal develop-
ment, inhibit calcium dependent enzymes and replace calcium at calcium 
dependent membrane receptor sites. 
Previous studies have demonstrated that ingestion of subclinical 
amounts of lead can lead to suppression of antibody synthesis, 
increased susceptibility to endotoxin and alterations in the phago-
cytic ability of macrophages. 
Since previous research has concerned itself primarily with the 
study of ingestion of substantial quantities of lead, the following 
research - has been conducted in an effort to understand the consequen-
ces of lead inhalation on health. Immunological impairment was an 
effective means of measuring the potential health hazards caused by 
lead due to the extreme sensitivity of the immune and hematopoietic 
systems to chemical toxicity. 
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LITERATURE REVIEW 
1. Sources and Emissions of Lead 
The extreme toxic effects of lead have been known for many years. 
Until recently, researchers have been concerned primarily with the 
clinical manifestations of severe lead toxicity on both the nervous 
and hematopoietic systems. With increased industrialization and 
motorized vehicle activity, and the subsequent increase of lead in the 
environment, emphasis is now being placed on the more subtle effects 
of lead. One active area of study is the imrnunotoxicity produced by 
lead (8). 
Two major pathways exist for the entry of lead into the body: 
ingestion and inhalation. The primary route is ingestion; for 
example, the consumption of tinned foods containing high concentra-
tions of lead (8). The Environmental Protection Agency (18) has esti-
mated that the daily dietary intake of lead by human males rang~s from 
100 to 500 ~g Pb/day. In the United States the incidence of lead 
poisoning by ingestion is alarmingly high; in 1969, 727 documented 
cases of lead poisoning were reported in New York City alone (8, 24). 
The majority of the ingested lead is in the elemental form and is 
rapidly excreted. Children afflicted with pica, resulting from the 
ingestion of paints containing lead chromate, account for a large per-
centage of the reported lead poisonings. Unlike the majority of 
ingested elemental lead which is rapidly eliminated, lead chromate is 
readily a bsorbed and stored by the body. 
Particulate lead, contained in the exhaust gases of combustion 
engines, is the other major source of lead pollution. Levels of par-
ticulate lead are monitored by the Environmental Protection Agency 
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(18). The acceptable level of atmospheric lead, as determined by the 
EPA, is not to exceed 2 ~g Pb/rn3. However, lead levels much higher 
than the acceptable standard have been recorded. During peak traffic 
hours in Los Angeles, Fishbein~ al (20) reported lead air concentra-
tions as high as 71.3 ~g Pb/rn3. This particulate lead exists largely 
as inorganic lead particles which vary in size. Much of the par-
ticulate lead is small enough (0.18 - 0.9 ~m) so as to allow for deep 
and rapid penetration into the pulmonary system (8, 18, 24). Larger 
particles are cleared by the mucocilliary escillator and ultimately 
swallowed. 
2. Biological Effects of Lead Exposure 
2.1.1 Metabolism of Ingested Lead 
The metabolism of inorganic lead depends upon a n~1mber 
of intrinsic factors. These factors include: dietary calcium, sex, 
and the types of tissue involved. 
Low levels of dietary calcium have resulted in increased lead 
absorption due to the competitive nature between lead and calcium (4). 
Lead replaces calcium at enzyme receptor sites via a chelating type 
effect (donor-acceptor). This binding appears to be principally a 
covalent type bonding rather than ionic (18). 
Barry~ al (5) have shown that sex influences the metabolism of 
lead. Non-occupationally-exposed adult males have 30% higher lead 
levels (164.8 mg) in both bone and soft tissue than do adult females 
(103.6 mg). With occupational lead exposure the total mean lead body 
burden increased to 566.4 mg in adult males. 
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Lead levels vary considerably depenrling upon the type of tissue; 
for example, lead levels in the aorta are generally 20 times higher 
than those in the muscle. Using a modified graphite tube furnace 
technique, Schlick et al (49) determined lead concentrations of vari-
ous tissues. They found that approximately 100 mg of orally admini-
stered lead acetate/kg body weight/day was the threshold dose required 
for a long-term increase in tissue Pb concentration. However, after 
30 days treatment, neither the threshold dose nor . 10 times this dose 
was sufficient to elevate the blood lead concentration, indicating 
rapid clearance of lead from the blood. Within three days after 
intravenous (IV) injections of a subclinical dose of lead, blood lead 
levels returned to control levels. 
More than 90% of the total lead body burden in adults is immobi-
lized in bone; the remaining lead is localized in soft tissue • . The 
Schlick study revealed that the concentration of lead in the soft 
tissues (liver and kidney) returned more slowly to normal than did 
blood lead levels but that lead bone content remained elevated for an 
extended period of time. Schlick ~ al interpreted the data to indi-
cate that the soft tissue function as an intermediate storage area, 
whereas the bone acts as a long term depot. The subclinical concen-
tration of lead used in the Schlick study has been shown capable of 
producing functional disorders of the reticulo-endothelial system, 
inhibition of the enzyme responsible for heme synthesis (ALA-d) and 
neurophysiological alterations. Since these disorders occur without 
producing elevated blood lead levels, the determination of blood lead 
level alone, may be inadequate for reliable measurement of lead accu-
mulation (13, 14, 49, 50, 57). 
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Similar experiments using monkeys yielded comparable results (57). 
The mechanism and pathway of lead mobilization during pregnancy were 
determined by Keller and Doherty (30). Pregnant mice were admini-
stered Pb in their drinking water. Results indicate that lead was 
primarily sequestered in maternal bone but that during gestation small 
amounts were also transferred directly to the fetus. During lactation 
lead was mobilized and subsequently transferred to suckling pups. 
Using these results as a model of lead mobilization, they concluded 
that approximately 5 mg lead would be transferred during the period of 
human lactation. 
2.1.2 Metabolism of Aerosolized Lead 
Whereas approximately 10% of ingested lead is absorbed, 
nearly 48% of inhaled lead is absorbed (12). The ultimate fate of 
inhaled particulate lead is dependent upon a number of physical and 
chemical factors which include: solubility, diffusibility, protein 
binding capabilities, chemotactic ability and size of the particle 
(11, 29, 1, 45). 
Chamberlain et al (12) reported that after a 50 hour post aeroso-
lization period of lead (0.5 ~m), 48% of the initial lung burden had 
been transferred to the blood. Excretion in fecal material after in-
halation was very slight, indicating that only a small amount of lead 
was cleared by the pulmonary cilia and swallowed. Renal clearance was 
extremely high and histological changes in tissue could readily be 
seen. 
Kehoe (29) reported that at low lead air concentrations a large 
portion of the particles trapped in the upper respiratory tract 
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with lead toxicity. Anemia . is associated with both severe lead intox-
ication as well as mild environmental lead exposure (41, 55). Lead-
induced anemia is due to the inhibition of the enzyme delta amino-
levulenic acid dehydratase (ALA-d), a required enzyme for heme synthe-
sis (2). This impairment may be due to the binding of lead directly 
to the enzyme rendering it functionally inactive. 
Another example of lead-induced enzyme dysfunction is the binding 
of lead to nucleosides. This binding results in improper coding for 
protein synthesis. An e~ample of this type of dysfunction is in the 
synthesis of certain enzymes required for oxidative metabolism (9, 22, 
23). 
2.3 Immunotoxic Effects 
2.3.1 Cellular Effects 
The effects of lead exposure on cellular viability 
and function have only recently been aetermined. These effects range 
from decreased enzymatic activity to lowered cellular replication. 
Kussel ~ al (40) demonstrated the effects of lead nitrate on nor-
mal proliferation of cultured cells. A definite inhibitory effect on 
the in vitro growth of a rat liver cell line, neuroblastoma cells and 
two glioma cell lines were reported with the addition of 1Q-5M lead 
nitrate to the culture medium. 
Mitogen-induced lymphocyte proliferation is inhibited with in ~ 
lead exposure. In ~ exposure to subclinical doses of lead inhi-
bited the proliferative response of lymphocytes treated with lipopoly-
saccharide (a B-cell mitogen), purified protein derivative (a T-cell 
mitogen) or phytohemagglutinin (aT-cell mitogen) (17, 39, 51). 
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Similarly, Koller and Roan (37) observed that the mixed lymphocyte 
culture reaction (MLR) using splenic lymphocytes from mice exposed to 
lead orally was not significantly altered. 
2.3.2 Effects on B-Lymphocyte Activity 
Oral exposure to subclinical doses of lead or cad-
mium resulted in significant impairment of B-cell function. Tne B-
cell is directly responsible for antibody formation. · Koller and 
Kovacic (35), using a modification of the Jerne plaque assay, reported 
that Swiss Webster mice exposed to subclinical doses of orally admi-
nistered lead acetate, demonstrated a marked decrease in antibody 
forming cells. Inhibition was evident in both the primary and secon-
dary immunologic response, the primary response being the first immu-
nologic response, composed primarily of IgM antibody; the secondary 
response is the memory or anamnestic response where largely IgG is the 
predominant antibody. The greatest impairment was observed on the 
secondary (IgG) response. 
In a similar study Koller, Exon and Roan (33) reported that lead 
administered by gastric intubation or injected intraperitoneally (IP) 
in mice stimulated the formation of 19S (IgM) antibody but caused a 
notable reduction in 7S (IgG) antibody in splenic lymphocytes. 
Faith and Kimmel (19) reported a decrease in B-cell function after 
chronic pre- and postnatal oral exposure of low levels of lead acetate 
in female CD rats. The total antibody levels of both the primary and 
secondary antibody response were markedly depressed in both pre~ and 
postnatal exposure groups. 
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2.3.3 Effects on Macrophage 
Macrophage play a key role in the defense mechanism 
of cellular immunity by inactivating and processing foreign particles 
and bacteria. The alveolar macrophage is the single most important 
factor involved in the removal of inhaled soluble particles (11, 28, 
45, 56). 
Exposure to lead has resulted in a number of adverse effects on 
macrophage. Effects of lead exposure on macrophage include such find-
ings as reported by Bouley~ al (7) who found reduced phagocytic 
activity in alveolar macrophage as measured by bacterial clearance and 
inactivation of aerosolized bacteria, in mice receiving aerosolized 
lead. Kiminski and co-worker (28) have shown that a high order of 
toxicity occurs when pulmonary macrophages are directly exposed 
(in vitro) to lead. Kiminski (28) also found that the reduced ~unc­
tional activity of macrophages following lead exposure results in the 
inhibition of oxidative metabolism, which is a prerequisite for intra-
cellular bacteriocidal activity. In addition, Trejo (54) demonstrated 
that a single intravenous injection of lead acetate impaired the pha-
gocytic ability of Kupffer cells. Electron microscopic examination of 
alveolar macrophage from mice exposed to aerosolized lead revealed 
structural damage to mitochondrial and endoplasmic reticulum which 
would alter enzyme synthesis and phagocytic ability (6). 
2.3.4 Effects on Acquired Immunity 
Numerous investigators have reported that ex~osure 
to lead can result in reduced resistance to certain bacterial and 
viral infections. Specific effects such as decreased antibody 
10 
production, impaired phagocytic ability and impaired detoxification by 
the liver have been reported (6, 7, 26, 35). 
Hemphill ~ ~ (25) found that mice injected IP with subclinical 
doses of lead nitrate over a 30 day period showed greater suscepti-
bility to IP challenge with Salmonella typhimurium than controls. 
Selye (52) found that rats which are ordinarily resistant to certain 
bacterial endotoxins were more susceptible to the action of these 
toxins when exposed to 1 mg lead acetate/100 g body weight admini-
stered IP. Similar results were obtained by Cook, Hoffman and DiLuzio 
(16). A single IV injection of 2 mg lead acetate/100 g body weight 
resulted in an enhanced susceptibility of Charles River rats exposed 
to Escherichia coli by IP challenge. 
Lowered pulmonary resistance to bacterial infection has been shown 
with lead exposure (7). Mice were administered lead via aerosoliza-
tion until a lung lead burden of 6 mg/mouse was achieved. Mice were 
then challenged with Pasteurella multocida via aerosolization. Lead-
exposed mice had an impaired immunological response which resulted in 
decreased resistance to the challenge bacteria. 
Lowered resistance to viral infection in lead exposed animals has 
also been documented. Koller (33) demonstrated an immunosuppressive 
effect in rabbits exposed to 2500 ppm lead acetate given in drinking 
water for 70 days. Rabbits were then immunized with pseudorabies 
virus. The antibody titers to the virus, as measured by the serum 
neutralization plaque assay, were significantly lower in the lead 
exposed animals than in the control animals. 
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2.3.5 Effects on Complement Activity 
Complement is one of the most essential non-
specific humoral factors in immunity. Complement is involved in the 
lysis, opsonization and inactivation of cellular, bacterial and viral 
antigens. Should the complement system be impaired, bacterial and 
viral virulence would be enhanced. 
There are two pathways by.which the lytic ability of complement 
may be fully activated. These pathways, the classical pathway and the 
alternate pathway, diff~r in the method of initial activation. The 
classical pathway depends upon the operation of nine protein compo-
nents (C1-G9) after activation by an antigen-antibody reaction. The 
alternate pathway is activated by a C3 convertase, an enzyme which is 
triggered by extrinsic agents such as endotoxin or microbial polysac-
charides. C3 convertase activates the alternate complement cascade 
starting with complement component C3 rather than C1 as is the case in 
the classical pathway. 
Decreases in complement activity after exposure to various heavy 
metals have been widely reported. Montgomery ~ al (44) reported that 
zinc, copper and manganese at concentrations greater than 100 ~ 
strongly inhibited complement-mediated hemolysis of antibody-
sensitized sheep red blood cells (srbc). This inhibition appeared to 
be due to the decreased formation of activated erythrocyte-antibody-
complemen t complexes. This theory was subsequently confirmed by 
Yamamoto and Takahashi (58) who found that both zinc and copper ions 
prevented formation of an active terminal complex ·by inhibiting C9 
binding. 
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In a similar study Montgomery, Chvapil and Zukoski (43) reported 
the in vitro effects of a wide range of zinc chloride concentrations 
(25 -500 ~M) on the activity of both free and cell-bound components of 
guinea pig complement. It was shown that all components were found to 
be inhibited by super-physiological concentrations of zinc ()100 ~M). 
In order for inhibition to occur, the addition of zinc had to be as a 
third reactant directly rather than addition after complement was cell 
bound. In addition, zinc did not cause irreversible denaturation of 
any component of complement. Studies by Muller-Eberhard ~~ (46) 
have shown that zinc and cadmium can block C2 activation, thereby ter-
minating the complement cascade at an early stage in the classical 
pathway and disrupting lysis. 
13 
MATERIALS AND METHODS 
1. Animals and Treatment Design 
1.1 Animals 
An outbred strain of Swiss Webster mice originally 
obtained from Charles River laboratories was used in this study. 
Animals were obtained from a breeding colony at South Dakota State 
University, Department of Microbiology. Food (Mouse Chow #5015 
Ralston Purina) and water were supplied ad libitum throughout all the 
experiments. 
Unless stated otherwise, Pb exposures began when the mice were 
14 days of age. Litters were sexed, randomly distributed into groups 
of 10 mice, and cross-fostered. 
1.2 Experimental Design 
1.2.1 Oral Lead Administration 
The lead ingestion group was administered lead 
orally via gastric intubation using a 1A cc graduated glass tuberculin 
syringe (Becton-Dickinson) and a balled bio-medical animal feeding 
needle (Perfekturn, Inc.). The lead ingestion group received a daily 
dosage of 125 ~g lead nitrate (Pb(N03)2) in 0.1 cc deionized water. 
Control mice received an equivalent quantity of deionized water. 
Animals we re treated for 14 days. 
1.2.2 Lead Aerosolization 
The lead aerosolization study contained two groups. 
The first group was placed into the aerosolization chamber at 14 days 
T 7 (' ., ," I (/ 
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of age. The second group was born and reared in the chamber. The 
chamber design was similar to that described by Arvik ~ al (3). The 
exposure chamber consisted of an ILE glovebox with an exhaust filter 
fan. Filtered air (air was from our "air valve") and a solution of 
1000 ppm Pb(N03)2 were forced through a nebulizer producing a liquid 
aerosol which was blown into a heated desolvation chamber. The spray 
entering the chamber was flash evaporated to produce water vapor and 
particulates composed primarily of lead. This passed into a condenser 
cooled to approximately 8°C. The larger dry particles of lead were 
removed by collision. with the walls of the condenser spiral. - The 
smaller sized particles passed through the spiral and entered the 
exposure chamber via a short piece of tygon tubing. Controls for this 
portion of the study remained outside the chamber. 
Mice were exposed to aerosolized lead for 14 days in the case of 
the two week old mice and four weeks in the case of the mice born and 
reared in chamber. 
Both groups were exposed to 2.5 mg Pb(N03)2/m3 or approximately 
80 11g Ph/mouse/day. This value was determined using data on the lung 
volume capacity and respiration rate of mice (47). 
It was determined with the use of an Andersen Cascade Impactor 
that 81% of the lead entering the chamber was of size <2 microns, 
allowing for deep penetration into the pulmonary system. 
2. Methods 
2.1 Immunological Methods 
2.1.1 Immunization 
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Sheep red blood cells from the same sheep and 
obtained no later than 7 days prior to immunization were used for all 
injections. Whole sheep blood was collected by jugular venipuncture 
in sterile 2 liter Erlenmeyer flasks containing 40 ml of 40% sodium 
citrate. After collection the srbc were transferred to sterile screw 
cap bottles and stored at 4°C. For injection the erythrocytes were 
washed three times in 0.85% saline and diluted to the desired 
concentration. 
After fourteen days of treatment, and at four weeks after birth in 
the case of the chamber born mice, each group of mice was injected 
intraperitoneally (IP) with 108 srbc in 0.25 cc sterile saline. On 
day 18, half of each group was anaesthetized with ether and terminated 
by exsanguination and cervical dislocation. The remaining mice were 
reinjected as previously described on days 18 and 22 and terminated on 
day 25 to determine the anamnestic or secondary immune response. 
2.2 Procurement and Treatment of Tissues, Blood and Serum 
Mice were anaesthetized with ether prior to exsanguina-
tion. Blood was collected by severing the subclavian artery. A 
sample of blood was allowed to clot for approximately 1 hour at room 
temperature. Using a wooden applicator stick, the clot was removed 
from the walls of the glass tube and dried for lead determinations. 
The serum was clarified by centrifugation and frozen until needed. 
Blood samples for total leukocyte counts, differential white blood 
cell determinations and hematocrits t-Tere also taken. After termina-
tion the mice were weighed and the thymus, lung, liver, kidney and 
spleen were removed, weighed and stored frozen in plastic vials for 
lead analysis by atomic absorption spectrophotometry. 
2.2.1 Hematocrit 
Heparinized microhematocrit capillary tubes were 
filled with whole mouse blood and centrifuged in an Adams Hematocrit 
centrifuge to determine the percentage volume of erythrocytes. 
2.2.2 Total Leukocyte Counts 
16 
Forty microliters of whole mouse blood from each 
mouse were added to separate disposable blood dilution vials contain-
ing 20 ml of Isoton II diluting buffer (Co.ulter Diagnostics, Inc.). 
Five drops of Zap Isoton II were addea to lyse erythrocytes. Le~ko­
cyte counts were made on a Model F Coulter Counter (Coulter 
Electronics). Two separate counts were taken, averaged and corrected. 
2.2.3 Differential Blood Counts 
Blood smears were made using a 3" x 1" bev-1-edge 
micro slide and stained in Cameo Quick Stain using the recommended 
procedure. A total of one hundred leukocytes was counted and dif-
ferentiated into monocytes, lymphocytes and neutrophils. 
2 .2.4 Cellulose Acetate Electrophoresis 
Cellulose acetate electrophoresis was performed to 
determine the relative proportion of the major serum components. 
Titan III cellulose acetate strips (Helena, Inc.) were submerged in 
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Electro HR electrophoresis buffer, pH 8.6 - 9.0 (Helena, Inc.), until 
saturated. An aliquot of 2 pl serum was applied to one end of a strip 
using a sample applicator. The slides were electrophoresed at 180V 
for 30 minutes at room temperature. The slides were stained in 
Ponceau S stain for 5 minutes, and destained in 3 consecutive baths of 
5% acetic acid. Clearing of the strips was accomplished by submerging 
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them in a Sepra Clear II cellulose acetate clearing solution .and 
heating in an 80°C oven until clear. The relative proportions of the 
major serum components were measured using a planimeter to determine 
the area of each component peak obtained from densitometer scans of 
the strips. 
2.2.5 Direct Hemagglutination 
All sera were tested for the presence of anti-srbc 
IgG and IgM antibodies using direct hemagglutination. These tests 
were performed using a modified microtiter assay similar to that of 
Stavitsky (53). The assay was performed in 96-well conical bottom 
microtiter plates (Linbro). All samples were run in duplicate in the 
following manner. Normal rabbit serum (1:100) in phosphate buffered 
saline (PBS), pH 7.4, was added to each well of the microtiter plate. 
The serum to be tested was added to the first well of each row and 
two-fold dilutions were made through the eleventh well using a micro-
dilutor (the twelfth well contained only PBS). To each of the wells 
an equal volume of 2% srbc suspension was added. After a two to four 
hour room temperature incubation, the results were recorded. 
Agglutination due to both IgG and IgM was obtained using 1:100 NRS 
in PBS as the diluent. Agglutination due to IgG antibody was 
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determined using a 1:100 NRS-PBS diluent containing 0.2 ~1 beta-mercap-
toethanol. Beta-mercaptoethanol is a reducing agent which selectively 
cleaves the disulfide bridges in the IgM molecule, leaving the IgG 
molecule functional. Titers were reported as the reciprocal of the 
last dilution showing any agglutination. A negative result was indi-
cated by a "button" of nonagglutinated cells. 
2.2.6 Complement Hemolytic Activity Determination 
To determine the effect of in vivo and in vitr~ 
lead exposure on the hemolytic activity of complement, the following 
assay was performed. 
2.2.6.1 In vitro lead exposure 
Reconstituted whole guinea pig complement 
(C') (BBL) was used throughout this procedure. The optimal con-
centration of complement, as determined by the SO% endpoint method of 
Burrell (10), was 5 CHso units. Two units of whole hemolysin (2H') 
(BBL) were used as the optimal hemolysin concentration for the sen-
sitization of sheep erythrocytes. 
Lead solutions used in the assay were lead acetate, lead chloride 
and lead nitrate diluted in isotonic saline at concentrations ranging 
from 25 ~M to 400 ~M. All samples were assayed in triplicate. 
Hemolytic assays were conducted by mixing in a clean 12 x 75 mm 
glass tube 1.5 ml of the test solution, 0.5 ml of the hemolysin solu-
tion containing 2 whole H' units, 0.5 ml 2% srbc, and 0.5 ml comple-
ment containing 5 CHso units. The mixture was incubated at 37°C for 
30 minutes with frequent agitation. After incubation the tubes were 
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centrifuged for 5 minutes and the optical density of each supernatant 
was measured at 541 nm to determine the amount of oxyhemoglobin 
released. The percent hemolysis was calculated by using the following 
formula: 
Absorbance 541 nm of test sample 
X 100 Absorbance 541 nm of 100% hemolysis control 
2.2.6.2 In vivo lead exposure 
Blood from 8 mice receiving aerosolized 
lead for 2 weeks and 8 control mice was collected in pre-chilled test 
tubes and placed immediately in an ice bath until clotted. Serum was 
obtained as previously described and assayed the same day to avoid 
loss of C' activity. A mixture consisting of 150 ~1 of a 1:2 dilution 
of the serum in pH 7.3 verona! buffered saline (VBS), 0.5 ml hemolysin 
containing 3 H' units diluted in VBS, 0.5 ml 1% srbc, and 1.85 ml of 
VBS were added to clean 12 x 75 mm glass test tubes and vortexed. 
Samples were then incubated at 37°C for 30 minutes with frequent 
shaking. After incubation the tubes were centrifuged and the optical 
density of the supernatant was measured at 541 nm. To correct for any 
hemolysis present in the mouse serum itself, 150 ~1 of a 1:2 dilution 
of serum was brought up to 3 ml in VBS and the optical density 
measured and subtracted from the final absorbance of the test sample. 
3. Biological Assays 
3.1 Phagocytic Index 
The phagocytic index was performed to evaluate the 
~ vitro phagocytic ability of both the alveolar and peritoneal 
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macrophage. 
Alveolar macrophages were harvested in the following manner. In 
order to prevent trauma to the lung, mice were euthanized by injecting 
0.3 ml of a 1:10 dilution of sodium pentobarbital (64 mg/ml). The 
trachea was exposed and a 16-gauge 2.5 inch Catholon IV Catheter 
Placement Unit (Jelco Lahs, Inc.) was inserted between the tracheal 
rings and secured. The lungs were lavaged using three 1 ml washes of 
sterile saline. The thoracic region was massaged externally for 
approximately 3 minutes prior to saline withdrawal and lavage fluids 
pooled. An average of 2.5 ml of lavage fluid was routinely obtained. 
Alveolar macrophages were sedimented by centrifugation at 400 g for 
15 minutes at room temperature and resuspended in 1 ml of medium 199, 
Hanks base (BBL) supplemented with 20% heat-inactivated rabbit serum. 
Viability and cell numbers were determined by the trypan blue exclu-
sion method (Appendix A). 
Peritoneal macrophages were harvested by washing the abdominal 
area with ethyl alcohol and carefully exposing the peritoneal sac. 
Three milliliters sterile saline were injected into the peritoneal 
cavity, massaged for 2 minutes and removed. This procedure was 
repeated and the peritoneal washes pooled. The macrophages were then 
sedimented, resuspended and counted as previously described. 
The technique used for the phagocytic index was a modification of 
the procedure used by Gardner~ al (21). Fluorescent yellow 0.8 ~m 
diameter polystyrene latex beads (Dow Chemical) were added to obtain 
an 18:1 latex sphere to macrophage ratio. The samples were incubated 
in a 37°C water bath for 30 minutes with frequent agitation. Following 
incubation, two 20 ~1 samples of the cell suspension were placed into 
each of the 2 etched rings of a 3" x 1" fluorescent antibody (FA) 
slide, air dried, and fixed in Bouins fixative (Appendix B) for 
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10 minutes. Following fixation the slides were washed in 50% ethyl 
alcohol for 3 minutes, placed into a 100% xylene bath for 3 hours with 
occasional shaking to dissolve the extracellular latex spheres, and 
rinsed with 50% ethanol. Macrophages were stained by placing the 
slides in a 0.001% fluorescent acridine orange saline staining solu-
tion, pH 10, for 4 to 5 minutes and rinsed. A drop of Bacto FA Mount-
ing Fluid (Difco, Inc.) was added to the two samples on each slide and 
covered with a Fisher brand 2 x 2 mm #1 coverslip. The number of 
ingested beads was counted using a Leitz Dialux UV scope with mercury 
cathode using the 40X and oil immersion objectives. The phagocytic 
index was calculated using the method of Carpenter (10). The number 
of latex beads phagocytized by ten macrophage from each mouse was used 
to determine the phagocytic index of each exposure group and respec-
tive control. 
3.2 LD5o Determination 
The effect of lead exposure on the susceptibility to 
bacterial challenge was determined by the intraperitoneal injection of 
serial dilutions of a 12-18 hour culture of Salmonella typhimurium 
into mice receiving subclinical amounts of lead. Mice were weighed 
and evenly distributed among groups according to weights in a random 
fashion. Six mice were injected with each dilution. The number of 
dead mice per dilution was recorded daily for 1 week. The LD5o, .stan-
dard error and 95% confidence limits were calculated by the method of 
Irwin and Cheeseman (27). 
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4. Chemical Methods 
4.1 Determination of Lead Content in Tissues 
Lead content in blood, serum, spleen, liver, lung and 
thymus was analyzed by atomic absorption spectrophotometry using a 
modification of the procedure used by Christian~ al (15). Following 
initial drying at room temperature, the previously collected tissue 
samples were dry-ashed at temperatures not exceeding 500°C. The 
spleen, lung lobe, thymus and blood samples were prepared as whole 
samples. Due to the mass of the liver and kidney, it was necessary to 
grind and weigh a portion of the sample being analyzed. Each sample 
was added to a 30 ml Kjedahl flask rinsed with 3 N hydrochloric acid. 
To each flask was added 5 ml of double distilled nitric acid. The 
mixture was boiled until approximately 2 ml of the nitric acid re-
mained, at which time 250 ~1 of perchloric acid and 2-3 ml of nitric 
acid were added and boiled to near dryness. The sample was solubi-
lized by adding 1 ml of deionized water to the flask, heating and then 
transferring it to a 5 ml volumetric flask and bringing it up to 
volume. 
Atomic absorption spectrophotometric analysis was performed using 
a Perkin Elmer model 503 AA spectrophotometer using argon as the 
carrier gas. The temperature and time settings were 30 seconds drying 
time at 150°C; 50 seconds charring time at SSOoC; and 7 seconds ato-
mizing time at 2300°C. The wavelength setting used was 283.7 nm, and 
the lead cathode was set at 10 rnA. Parts per million lead was deter-
mined using a standard curve of 0.05, 0.1, and 0.15 . ppm lead 
solutions. All test samples and controls were run in triplicate. 
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5. Statistical Analysis 
All statistical analyses were performed with a Texas Instrument 58C 
calculator. Data were evaluated by the one way analysis of variance. 
Levels of significance are reported at the 99 and 95% levels. 
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RESULTS 
1. Lead Exposure 
1.1 Aerosolization 
The level of lead nitrate used for aerosolization was 
2.5 ~g/m3 as determined using an Anderson Cascade Impactor. Using the 
lung volume and respiration rates for mice (47), it was determined 
that each mouse was inhaling approximately 80 ~g Pb/day. At the lead 
concentration used, no overt clinical symptoms of lead toxicity were 
observed. 
1.2 Oral Exposure 
The level of oral lead exposure was chosen to correspond 
to the concentration of lead received by the lead aerosolized mice. 
The oral dosage of lead was 125 ~g Pb(NOJ)2/mouse/day. The two 
natural exposure routes of lead were compared to respective controls 
and to one another to assess the most immunotoxic route of exposure. 
2. Effects of Lead on the Immune and Hematopoietic Systems 
2.1 Hematocrit Values 
Neither the oral lead exposed group (Pboral), the two 
week aerosolized lead group (Phair), nor the chamber born group (Pbch) 
had significantly different hematocrit values when compared to control 
group Coral (deionized HzO gavage) and Cair (non-aerosolized). Since 
clinical lead toxicity has been shown to result in major hematocrit 
changes, the dosage of lead administered in this experiment was of a 
subclinical level. 
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2.2 Organ to Body Weight Ratio 
Organ to body weight ratios were performed to determine 
the effects of lead on specific lymphoid organs (Table 1). 
Of the five organs compared (lung, kidney, liver, thymus and 
spleen) in the orally lead ingested group, no significant differences 
were seen. 
In group Pbair highly significant decreases in organ to body 
weight ratios occurred in the thymus and spleen samples when compared 
to controls. In addition, a highly significant increase in the organ 
weight ratio of the kidney occurred in this group. 
Organ to body weight ratios which occurred in group Pbch when come 
pared to controls included highly significant decreases in spleen and 
liver samples, with a highly significant increase in the kidney to 
body weight ratios. 
2.3 Total Leukocyte Counts 
Total leukocyte counts were determined to assess the 
effects of subclinical ~ ~ lead exposure on white blood cells 
(WBC). The results are shown in Table 2. The totat WBC count in 
group Pboral did not differ significantly from the oral control group 
receiving deionized water. The two week lead aerosolized group also 
had similar cell counts compared to the non-aerosolized control group 
Cair• A highly significant reduction was observed in group Pbch when 
compared to control group Cair• The longer lead exposure together 
with the cumulative nature of lead might account for the reduction in 
white blood cells. 
Table 1 
Organ to Body Weight Ratios 
Of Mice Exposed to Pb by Ingestion or Inhalation& 
Group (%} Kirlney/Body (%) Thymus/Body (To) Spleen/Body (%} Liver/Body (%) Lung/Body 
Orally Fed Control (Coral) 1.48 0.40 0.62 6.28 0.97 
± .07 ± .o s ± .OR ± .34 ± .os 
Orally Fed Lead {Pboral> 1.46 0.38 0. 62 6 .68 0.94 
(75 llg Pb/day) ± .fl7 ± .08 ± .26 ± .24 ± .06 
Non-aerosolized Control 1.43 0.39 0. 62 7.48 0.96 
(Cair) ± .07 ± .07 ± .25 ± .92 ± .11 
Aerosolized Lead {Pbatr> 1 . 63 0.27 0.46 6.91 0.96 
(80 l!g Ph/day) ± .o7b ± .o7h ± .o6h ± .60 ± .10 
Chamber Born (Pbch) 1.9 0.31 0.41 5. 76 1.05 
( 80 l!g Pb/ day) ± .19b ± .04 ± .o7h ±.6oh ±.0.7 
a Mean ± S.D. 
b p < 0.01 as determined by the Analysis of Variance method 
c Ten mice were observed in each dosage group. 
I'V 
(J) 
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2.4 Differential Cell Counts 
To determine changes in cell populations due to in vivo -- ----
exposure to subclinical amounts of lead, differential cell counts were 
done. The results of the cell counts are listed in Table 2. No 
significant differences were observed between groups Pboral and 
controls Coral• Comparing lead aerosolized groups Pbair and Pbch to 
controls Cair, a neutrophilic shift to lymphocytes was observed. A 
significant reduction in monocytes also occurred in group Pbair• 
2.5 Cellulose Acetate Electrophoresis 
Changes in serum globulins due to lead exposure were 
measured by cellulose acetate electrophoresis and are reported in 
Table 3. .The serum profiles for group Pboral were similar to Controls 
Coral, indicating no alterations in the serum proteins with this route 
of exposure. Serum profiles of the two week lead aerosolized group 
when compared to nonaerosolized controls, indicated a significant re-
duction in the gamma globulin peak. The gamma region is the electro-
phoretic region which contains antibody. The other electrophoretic 
regions (albumin, alpha and beta globulins) were within normal range. 
In group Pbch a highly significant decrease in the gamma globulin 
region was noted as well as a decrease in the beta globulin peak, when 
compared to controls Cair• The beta globulin region contains notable 
serum proteins such as plasminogen, fibrinogen, complement components, 
activators and inhibitors. The albumin region in group Pbch increased 
to a highly significant degree to compensate for the decreases in 
gamma and beta globulins. The reduction in the gamma globulin region 
Table 2 
Differential and Total Leukocyte Counts 
Of Mice Exposed to Lead by Ingestion and InhalationC 
{%) {%) {%) 
Group Lymphocyt~~-- -~~---___B~~t:~_Qphils Honogte 
Orally Fed Control 73.3 ± 4.9 19 . 5 ± 2.5 
(Coral) 
Orally Fed Lead 70.6 ± 8.4 23.2 ± 6.6 
(Pb0 ral) (75 pg Ph/day) 
Non-aerosolized Control 70.6 ± 5.4 23.2 ± 4.1 
(Cair) 
Aerosolized Lead 79.8 ± 3.8a 15.8 ± 3.2a 
(Phair) (80 llg Ph/day) 
Chamber Born 86.3 ± 3.4a 10.2 ± 3.2b 
(Pbch) (80 llg Ph/day) 
a p < 0.05 as determined by the Analysis of Variance method 
b p < 0.01 as determined by the Analysis of Variance method 
c Mean ±S.D. 
d Ten mice were observed in each dosage group. 
7.2 ± 2.1 
6.2 ± 4.4 
6.2 ± 2.2 
4.4 ± 0.9a 
3.5 ± 0.8 
Total Leukocyte 
1 7 , 6 3 3 ± 58 R 7 / ml 
16 , 2 7 5 ± 2 31 0 I ml 
19,840 ± 9354lml 
19,950 ± 8227 lml 
16 , 4 7 5 ± 3 7 6 8 I ml a 
N 
co 
Table 3 
Selected Effect of Lead on Serum Proteins 
In Lead Exposed Micec 
( ~) (%) 
tAlph~ •r 
Ora lly Fed Cont rol 62 .. 6 ± 4.1 [} .. 4 ..<: 2"0 
Oral ly Fed Lead 60o0 :i: 6 .. :.. 11.3 ± 4,.2 
(75 ~g Pb/day) 
Non-aerosolized Cont rol 56el ± )&fj lO .. A ::: z .. q 
Aerosolized Lead 59 . 9 ± 4 .. 8 1L.9 ± Z~2 
(80 ~g Pb/day) 
Chamber Born 67 . 9 ± 2. sb 10 . 5 ± 2. 4 
( 80 ~g Pb/ day) 
a p < o.os as determined by the Analysis of Variance method 
b p < 0.01 as determined by the Analysis of Variance method 
c Mean ±S.D. 
d Ten mice were observed i~ each dosage group. 
(%) 
Beta 
/,Jj :::: Z"4 
"/1):1 -: 4 .. 0 
7 . 6 ± 2 . 0 
8 . 6 ± 3.3 
5.1 ± 1.3b 
(%) 
Gamma 
2.1 .. 4 :::~eO 
210)2 ± 4. 9 
25 . 9 ± 4.1 
19 . 6 ± 3.7a 
16.5 ± 2.2b 
N 
\0 
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in both lead aerosolized groups is the first indicator in this study 
that the subclinical concentration of lead used is imm1nosuppressive 
when inhaled. Furthermore, it appears that with longer lead exposure, 
as with group Pbch, additional alterations in serum globulins can 
occur. 
2.6 Direct Hemagglutination 
The direct hemagglutination test (HA) combines high 
degrees of both sensitivity and specificity in measuring antibody to a 
specific antigen. The immunogen used in this study was srbc, which is 
both a T- and a B-ce ll immunogen. To differentiate the IgG antibody 
response from total antibody (IgG and IgM), S-nercaptoethanol was 
used. Hemagglutination titers for the orally ingested lead group 
(Pb
0
ral) were similar to control group Coral receiving deionized 
water. This was the case for both the primary and secondary immunolo-
gic responses. These results compare favorably with the serum profile 
results for this group in respect to the 'normal' level of gamma glo-
bulin of group Pboral• With lead aerosolization, the HA titers for 
the primary immunologic response of both groups Phair and Pbch showed 
a highly significant decrease compared to controls Cair• The primary 
immunologic response is mainly due to 19S (IgM) antibody as determined 
with the use of S-mercaptoethanol. The HA titers for the secondary 
immunologic response in the two week lead aerosolized group Pbair rose 
to an equivalent titer as the control group Cair for both total (IgG 
and 1~1) and 75 (IgG) antibody. The secondary response is due pri-
marily to IgG antibody. Secondary immunologic HA titers for group 
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Table 4 
Hemagglutination Titers of Mice 
After Pb Ingestion 
Group 
Orally Fed Control: primary 
response 
Orally Fed Control: secondary 
response 
Orally Fed Lead: primary 
response 
( 7 5 llg Pb I day) 
Orally Fed Lead: secondary 
response 
( 7 5 llg Pb I day) 
Total Antibodya 
and 
95% Confidence 
Intervals 
96 (73-115) 
2048 (1536-2816) 
96 (80-122) 
2048 (1536-2816) 
Beta-mercaptoethanol 
resistant (IgG) 
<4 
96 (81-105) 
<4 
128 (112-144) 
a Titers expressed as the geometric mean. 
b Ten mice were observed in each group, five for the primary response 
and five for the secondary response. 
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Table 5 
Hemagglutination Titers of Mice 
Exposed to Aerosolized Lead 
Group 
Non-aerosolized Control: 
primary response 
Non-aerosolized Control: 
secondary response 
Two week Aerosolized 
Lead: primary response 
(30 1-Jg Pb/day) 
Aerosolizerl Lead: 
secondary response 
(80 ~ Pb/day) 
Chamber Born: 
primary response 
( R 0 ll£ P b Ida y) 
Chamber Born: 
secondary response 
( 8 0 llg P b Ida y) 
Total Antihody 
and 
95% Confidence 
Intervals 
192 (164-282) 
256 (172-289) 
32a (22-40) 
192 (163-229) 
16a (15-18) 
64a (51-73) 
Beta-mercaptoethanol 
resistant (IgG) 
8 (6-8.5) 
128 (92-165) 
4 (3.5-5) 
128 (91-143) 
not performed 
32a (30-40) 
a p < 0.01 as determined by AOV 
b Ten mice were observed in each group, five for the primary response 
and five for the secondary response. 
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Pbch compared to Cair remained significantly suppressed in both total 
antibody and IgG antibody. 
2.7 Complement Hemolytic Activity 
The measurement of hemolytic complement activity is a 
widely used assay which serves as a convenient quantitative method to 
identify decreased complement activity. 
2.7.1 In vitro Lead Exposure 
The three lead compounds tested in the in vitro 
portion of the hemolytic complement assay were lead acetate, lead 
chloride and lead nitrate. All of the lead compounds were inhibitory 
on hemolytic complement activity. The degree of inhibition was depen-
dent upon the concentration of lead added. The levels of inhibition 
(Table 6) are typical of the type of inhibition caused by a number of 
other heavy metals on complement activity. As we observed at levels 
) 100 ~M, lead inhibition was produced up to the highest concentration 
of lead used. Inhibition values for lead nitrate at concentrations 
> 300 ~M could not be obtained due to the lytic effects of higher con-
centrations of this compound on sheep erythrocytes. 
For all compounds tested at concentrations less than 100 ~M, no 
inhibition was observed. 
To determine whether a competitive reaction existed between lead 
and calcium-magnesium, various concentrations of calcium-magnesium 
saline were added to the lead solutions prior to incubation with srbc. 
The final concentrations of calcium-magnesium used were 1000, 800, 
500, 400 and 200 ~M solutions. Inhibition of all lead compounds 
Table 6 
Inhibition of Complement Induced Hemolysis by Leada 
Lead Solution Used 
A. Lead Nitrate 
2 50 ll H 
200 llM 
150 ll 11 
100 ll H 
B. Lead Acetate 
400 ].lH 
3 50 ll H 
300 ll M 
2 50 ll H 
200 J.lH 
150 ll H 
100 J.lM 
c. Lead Chloride 
400 J.lM 
350 J.lH 
300 ].lM 
250 11M 
200 11M 
150 11M 
100 11H 
Percent Inhihition 
75.4 
19.2 
1.5 
1.5 
90.0 
89.0 
86.5 
13.1 
10.0 
4.4 
1.5 
87.0 
85.5 
63.2 
27.5 
4.4 
2.5 
2.5 
a All solutions prepared in isotonic saline 
solution. 
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tested was reversed with the addition of a calcium-magnesium saline 
solution twice the molarity of the lead solution causing inhibition. 
2.7.2 In vivo Lead Exposure 
Results of the hemolytic C' activity in sera of 
mice exposed to aerosolized lead for two weeks are shown in Table 7 , 
along. with serum lead values. A 1:2 dilution of serum was used to 
measure the hemo-lytic complement levels of both a lead aerosolized 
group and a nonaeroso-lized control group. Activity of complement in 
serum was reduced to a highly significant degree (approximately 12%) 
in the lead exposed group compared to controls. The average serum 
lead content as determined by AAS for the two week lead aerosolized 
group (1.49 ppm) was ten times higher than that of the controls (0.147 
ppm). 
3. Biological Assays 
3.1 Phagocytic Index 
To determine the effects of lead exposure on the phago-
cytic ability of peritoneal and alveolar macrophage (M~), a phagocytic 
index was determined on ingested and aerosolized lead groups and their 
respective controls. 
3.1.1 Phagocytic Index of Orally Exposed Lead Groups 
The phagocytic index (PI) of both peritoneal and 
al 1 M~ i Pb 1 did not differ significantly from control veo ar ~ n group ora 
group Coral• 
The number of alveolar and peritoneal M~ harvested i"rom 
also similar to the number of phage-the orally exposed lead group was 
cytes harvested from the control. Results of the PI and number of 
Table 7 
Hemolytic Complement Activity .of Serum 
After In Vivo Exposure to Aerosolized Pb 
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Group Average Serum Lead Concentration 
Average 
Percent Hemolysis 
Control 
(Non-aerosolized) 
Two Week Lead 
(Aerosolized) 
a p < 0.01 
0 • 14 4 ± 0 • 0 0 7 ppm 92.5 ± 5. 3 
1.485 ± 0.07 ppma so.5a± 7.6 
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cells harvested are given in Table 8. With the results obtained thus 
far it appears that with lead ingestion at the subclinical levels used 
in this experiment, much of the lead entering the body is rapidly eli-
minated and excreted, thus allowing for normal phagocytic ability of 
both alveolar and phagocytic macrophage. 
3.1.2 Phagocytic Index of Aerosolized Lead Group 
The phagocytic index for the peritoneal M~ of 
groups Pbair, Pbch and the control group Cair is given in Table 8. 
Inhalation of lead at the quantity and duration as used in this 
experiment did not appear to effect the phagocytic ability of the 
peritoneal macrophage. The quantity of cells harvested froo the lead 
exposed mice was also comparable to numbers of cells harvested from 
the respective controls. It appears therefore that the peritoneal M~ 
does not contribute to the immunosuppressive effect elicited by lead. 
The major cellular effect of aerosolized lead appeared to be on 
the alveolar macrophage of both groups Pbair and Pbch• As the results 
in Table 9 indicate, a highly significant decrease in the PI was 
observed when compared to the control group Cair• The number of 
alveolar M~ recovered from both aerosolized lead groups was 3.5 times 
the number of cells recovered from the non-aerosolized controls. 
3.2 LDso Determination 
orally lead exposed mice and two week lead aerosolized 
mice along with controls for each group were challenged IP with 
Salmonella typhimurium to determine the LDso. The LDso results are 
given in Table 10, along with the standard error and confidence 
Table 8 
Phagocytic Index of Peritoneal Macrophages Harvested 
By Saline Lavage in Lead Exposed Mice 
Group 
Control Groupb 
Orally Fed Leadb 
(75 llg Pb/day) 
Two Week Lead Aerosolizedb 
(80 ll& Pb/day) 
Chamber Bornb 
(80 llg Pb/day) 
a Mean ten mice/group ± S.D. 
Phagocytic Index 
2.3 . ± 0.66 
1.9 ±0.45 
2.2 ± 0.57 
2.7 ±0.93 
Harvested Cells 
(cells/ml) 
1.45x106 ± 1. 5x106 
1.72x106 ± 8.5x105 
2 .23x106 ± 1.0x106 
1.46xl06 ± 6.8x105 
b The number of fluorescent beads in ten macrophage per slide were 
counted to determine the phagocytic index. 
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Table 9 
Phagocytic Index of Alveolar Macrophages Harvested 
By Lung Lavage in Lead Exposed Mice 
Harvested Cells 
Group Phagocytic Indexc (cells/ml) 
----------------~~----
Control Groupb 
Orally Fed Leadb 
(75 llg Pb/day) 
Two Week Lead Aerosolizedb 
(80 llg Pb/day) 
Chamber Bornb 
(80 llg Ph/day) 
6.1 ± 0.68 
5.6 ± 0.63 
4.3 ± 0.75C 
4.5 ± 0.89C 
1.4xlo5 ± 4. 7:·do4 
2 .3xlo5 ± 1.6xlo5 
5 .lxlo5 ± 1.4xl05c 
6.3xlo5 ± 1.4xlo5c 
a Mean ten mice/group ± S.D. 
b Ten macrophage/mouse were counted for phagocytic index. 
c p < 0.01 as determined by one way AOV. 
Table 10 
Results of Lethal Dose 50 
In Lead Exposed Mice 
Using the Organism Salmonella typhimurium 
Group LDso and 95% Confidence Intervalsa 
Orally Fed Control 
Orally Fed Lead (75 ~ g Pb/day) 
Non-aerosolized Control (80 ~g Pb/day) 
Aerosolized Lead (80 ~ Pb/day) 
3.31xl05 CFU/mouse 
(4.3xl04 ~ 2.Sxl06) 
1.89xlo5 CFU/mouse 
(2.3xlo4 - 9.4xl05) 
2.02xl08 CFU/mouse 
(1.2xl08 - 8.0xl08) 
1.57xl06 CFU/mouse 
(2.4xl05 - 9.9xl06) 
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a Irwin-Cheeseman (27) method used to determine 95% confidence levels. 
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intervals as determined using the method of Irwin and Cheeseman (27). 
In the ingested lead group, Pb0 ral, similar LDso values were obtained 
as for control group Coral, indicating no impairment of the immune 
system. In group Pbair a 128-fold difference in the LDso was seen 
when compared to the LDso for the nonaerosolized controls. It would 
appear that aerosolized lead does alter the immune system causing an 
immunosuppressive effect, when a gram negative organism is injected. 
4. Chemical Methods 
4.1 Atomic Absorption Spectrophotometry 
Subclinical quantities of lead which are ingested are 
rapidly eliminated from the body, as reported previously. This 
appears to be the case in this study. Of the five organs measured for 
lead content, only the kidney indicated an increase in lead content 
compared to controls Coral• As a two-fold increase was observed in 
this group, these results compare favorably with results obtained by 
Koller ~ al. (33) who also reported increased kidney lead content 
with ingestion of subclinical amounts of lead in mice. 
Inhalation of lead resulted in a greater retention with accumula-
tion of lead in the kidney, liver, lung, thymus and serum. In group 
Pbair, the kidney lead content was raised nearly four fold over the 
control group Cair• In addition, a highly significant increase in 
liver lead content and lung lead content was observed, as well as a 
significant increase in serum lead content when compared to the 
control group. Significant increases in the thymus, . liver and lung 
lead contents of group Pbch was observed compared to controls Cair• 
The spleen and blood lead levels did not differ significantly from 
controls in either of the aeerosolized lead groups. 
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Table 11 
Lead Concentrations in the Tissues and Blood 
Of Mice Exposed to Ingested or Aerosolized PbC 
-------------------------- Mean parts per million Leadd ----------------------- --
Group Thymus Spleen Liver Lung Kidney Blood 
Orally Fed Control 20.1 ± 7.9 16.2 ± 9.1 29.7 ± 11.3 9.7 ± 5.9 11.9 ± 4.6 3.8 ·± 1.0 
Orally Fed Lead 14.3 ± 8.2 17.9 ± 12.4 31.0 ± 9.7 8.2 ± 1.5 21.5 ± 5.8a 4.7 ± 2.4 
Non-aerosolized Control 21.2 ± 10.0 14.8 ± 5.6 22.4 ± 5.4 6.2 ± 0.79 12.0 ± 5.0 3.6 ±1.0 
Two Week Aerosolized Lead 32.2 ± 13.6 39.5 ± 18.8 63.3 ± 12.6b 54.9 ± 35.88 43.8 ± 13.9b 4.9 ± 3.8 
Chamber Born 43.9 ± 16.2a 43.1 ± 28.5 53.9 ± 23.08 101.8 ± 66.08 50.4 ± 12.2b 5.5 ± 2.5 
a p < 0.05 as determined by the Analysis of Variance method 
b p < 0.01 as determined by the Analysis of Variance method 
e Mean of 10 mice± S.D. 
d Results reported as parts per million lead in organ dry weights 
+ 
w 
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DISCUSSION 
The effects of toxic substances have been evaluated by parameters 
such as carcinogenicity, teratogenicity, embryogenicity and neuro-
toxicity. The study of alterations in immunocompetence by toxic sub-
stances has been greatly neglected in the past. This oversight may 
pose a serious hazard since toxic substances can impair the capacity 
for mounting immunological reactions which seriously endangers the 
health and life span of both man and animal. Recently the immuno-
suppressive effects of lead exposure have been assessed using criteria 
such as those in this study. 
1. Effects of Lead on the Immune and Hematopoietic Systems 
1.1 Hematocrit 
Anemia is one of the first clinical indications of lead 
toxicity. Although it is known that anemia occurs with severe lead 
intoxication, the threshold blood lead level at which anemia occurs 
has not been clearly established (18). Hematocrit levels as deter-
mined in this study are used as an indicator of anemia. 
Hematocrit levels of the lead administered groups were not signi-
ficantly different from those of control animals. This result 
suggests that a subclinical level of lead was administered in this 
study. 
1.2 Organ to Body Weight Ratios 
Organ to body weight ratios were calculated for lymphoid 
organs to determine changes produced by lead exposure. Animals 
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administered lead orally had no statistically significant differences 
in organ to body weight ratios compared with control animals. This 
finding is not unusual since 1) the concentration of lead used was of 
a subclinical level and 2) a large portion of ingested lead (-90%) is 
rapidly excreted from the body (29). 
Animals in the lead inhalation group had significant weight 
changes in a number of organs. Animals exposed for two weeks, 
Phair had a highly significant (p < 0.01) decrease in the thymus to , 
body weight ratio. This decrease was not observed in the chamber born 
Pbch group, although a 21% decrease in thymus weight did occur. 
Whether the observed thymic atrophy associated with these groups 
resulted directly or indirectly in a T-cell dysfunction (31,32) was 
not assessed. 
The spleen to body weight ratio in both aerosolized lead groups 
was decreased significantly (p < 0.01). The spleen is associated with 
the humoral or antibody mediated immune response, therefore, this 
decrease in organ weight could be associated with reported impairment 
in B-cell immunity (31,32,33,35). 
Hepatic atrophy occurred only in the chamber born group 
(p ( 0.01). The liver serves as a detoxification organ containing a 
number of enzymes that are required for endotoxin neutralization which 
might account for the enhanced susceptibility previously observed 
(52). 
Kidney to body weight ratios in both group Pbair and Pbch 
increased to a highly significant degree compared with control group 
Cair• Similar increases in kidney weights have been reported by a 
number of investigators (34). The kidney is also an essential 
filtrate organ containing numerous enzymes used in neutralization. 
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The lung to body weight ratio remained normal in both aerosolized 
groups compared with controls. 
1.3 Total and Differential Leukocyte Counts 
The cytotoxic nature of lead has been clearly demonstrated by 
a number of investigators (40) who have shown that extremely low 
levels of lead (lo-5 M) can cause cellular death. This toxicity 
appears to involve lysosomes, inclusion bodies and reduced cellular 
enzymatic activity. 
Alterations in leukocytes may lead to impaired humoral as well as 
cellular immune responses, therefore, total and differential leukocyte 
counts were performed to.determine any changes in these parameters. 
Differential counts as well as total leukocyte counts remained un-
affected in the orally administered lead group compared with controls. 
Again this is further evidence that a large proportion of the ingested 
lead is excreted prior to entering the circulatory system. 
Both aerosolized lead groups, Pbair and Pbch, had significant 
changes in total and differential leukocyte counts. A significant 
neutrophilic shift to lymphocytes was observed in both groups. Group 
Phair had a significant (p < 0.05) increase in lymphocytes and a 
highly significant (p < 0.01) decrease in neutrophils. Group Pbch had 
a significant (p < 0.05) increase in lymphocytes and a significant 
decrease in monocytes. Both monocytes and neutrophils serve as phago-
cytic cells, and a decrease in both cell types may lead to lowered 
bacterial clearance and decreased cellular immunity. 
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1.4 Cellulose Acetate Electrophoresis 
Through cellulose acetate electrophoresis the major globulins 
found in serum can be separated and quantitated to determine changes 
in these globulin fractions. The serum globulins are separated into 
four basic groups; albumin, alpha globulins, beta globulins and gamma 
globulins. 
Sera obtained from the orally lead administered group indicat ed no 
abnormalities in globulin fractions compared with control sera, 
whereas both aerosolized ~ead groups had reduced globulin fractions. 
The gamma globulin fraction which contains the majority of immunoglo-
bulins was reduced by 24% in group Pbair and by 36% in group Pbch• In 
addition, the beta globulin fraction containing complement associated 
proteins and blood clotting factors was reduced to a highly signifi-
cant level in group Pbch ()40% reduction). The albumin level in - this 
group increased 17% to compensate for the reductions in gamma and beta 
globulin levels. 
A reduction in antibody levels as well as immunoglobulin synthesis 
with lead exposure have been previously reported (8,16,18,25,31-38, 
42). A major finding thus far in this study is that significant immu-
nosuppression has been established with exposure to lead at levels 
considered subclinical and in quantities approaching levels found in 
urban centers. 
1.5 Direct Hemagglutination 
To measure the overall competence of the immune system a 
direct hemagglutination assay was performed on experimental and 
control animals. The direct hemagglutination assays both T and B cell 
function and combines high degrees of sensitivity and specificity 
using sheep red blood cells as the antigen. 
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Titers for group Pboral were comparable to control Coral• These 
results were in agreement with the serum profiles obtained for this 
group discussed in the previous section. 
Both aerosolized groups (Phair and Pbch) had highly signifiqantly 
lowered primary antibody responses for IgM (19S) antibody compared 
with control Cair• 
The secondary response of the two week lead aerosolized group was 
comparable to that of the control group, whereas the secondary anti-
body response in group Pbch remained significantly (p < 0.01) 
suppressed. 
These data correlate with the results of the electrophoretic serum 
profiles which indicated reduced gamma globulin fractions. Whether 
impairment in antibody synthesis is due to dysfunction in the T-cell 
orB-cell populations was not established. Koller and Kovacic (35), 
who reported lowered antibody response to srbc in mice exposed to 1300 
ppm lead acetate administered orally, suggested the specific impair-
ment was due to T-helper cell dysfunction. This fact as yet has not 
been conclusively established. 
1.6 Complement Hemolytic Activity 
Complement refers to a group of interacting serum proteins, 
many of which are capable of enzymatic activity. Complement was ori-
ginally detected by its ability to cause cytolysis of antibody sen-
sitized (bound) bacteria and erythrocytes. It is now clear that 
complement mediates a number of additional reactivities other than 
cytolysis, such as opsonization and chemotaxis (43,44). 
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Eleven complement proteins have been identified in the usual anti-
body initiated hemolysis; these comprise the classical pathway. A 
number of these components require calcium for their integrity and for 
reactivity. The most calcium dependent is the Cl complex, consisting 
of three proteins, Clq, Clr and Cls, linked together by calcium (10). 
1.6.1 In vitro lead exposure 
Our data on the effects of three lead compounds on 
complement activity indicated that lead at concentrations )100 ~M pro-
duced a profound inhibitory effect on hemolysis. The amount of inhi-
bition to hemolytic complement activity was concentration dependent 
with the greatest inhibition observed at the highest lead concentra-
tion ()300 ~M). Lead nitrate levels )300 ~M caused a lytic effect and 
therefore inhibition could not be determined. At lead concentrations 
(100 ~M no noticeable inhibitory effects occurred. These results are 
comparable to those obtained for other heavy metals which produced 
inhibition of hemolytic complement activity (43,44). 
This inhibitory effect was found to be reversible with the addi-
tion of Ca-Mg saline at twice the concentration of the lead solution 
which caused inhibition. It is therefore apparent that lead inter-
feres with the binding of components either by 1) causing a separation 
of the Cl complex through replacement of Ca by Pb, 2) replacing 
calcium at receptor sites which may require calcium~ or 3) replacing 
calcium required for the enzymatic action of specific complement 
components. 
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1.6.2 In vivo lead exposure 
Hemolytic complement activity in mice exposed to 
aerosolized lead for a two week period was inhibited 12% compared with 
normal non-aerosolized controls. These results are similar to those 
obtained by Montgomery et al. (44) in which zinc glycine injected 
intravenously in rabbits at two to three times the physiological serum 
zinc concentrations resulted in significant inhibition of total C' 
activity in sera of treated rabbits. 
Lead serum levels determined by atomic absorption in group 
Phair mice revealed a 10-fold increase in Pb compared to nonexposed 
controls. This is unusual since the majority of lead was found to be 
contained in serum rather than in the blood clot containing the red 
blood cell portion. 
2. Biological Assays 
2.1 Phagocytic Index 
Phagocytosis serves a critical role in the clearance of 
foreign substances. Bacteria, viruses and foreign particles are 
readily eliminated by specific phagocytic cells, generally macrophages 
(M0). Three major groups of M~ exist, the alveolar macrophage found 
in the lungs, the Kupffer cells found in the liver and the peritoneal 
macrophages located in the peritoneum. The phagocytic activity of the 
alveolar and peritoneal macrophages were measured in this study. 
Lead administered to mice via gastric intubation caused no impair-
ment of phagocytic activity in either alveolar or peritoneal macro-
phage. The number of M0 harvested froo each area was equivalent to 
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the number harvested from control group Coral• These data are not 
unusual in that other parameters measured up to this point for group 
Pboral have resulted in no statistically significant changes, indi-
cating rapid clearance of ingested lead. 
In both aerosolized lead groups (Pbch and Pbair) the phagocytic 
index (PI) and number of M~ harvested from the peritoneal cavity ere 
equivalent to those obtained from control group Cair• 
A 21% decrease in the PI of alveolar M9 resulted in groups Pbair 
and Pbch, whereas, the number of alveolar }10 collected from these 
groups was 3.5 times the number harvested from group Cair• Impaired 
phagocytic ability was anticipated in this group for the following 
reasons: 1) lead suppressed humoral antibody formation; ~) lead 
nitrate injected intraperitoneally impaired Kupffer cell phagocytosis 
(54); and 3) bacterial clearance was impaired following lead instilla-
tion (7). The increase in the number of cells harvested from the 
lungs was an unusual finding in that a number of investigators have 
clearly demonstrated the cytotoxic property of lead and other heavy 
metals on M0 (6,7,11,28,36,45). 
It appears that much of the inhaled lead enters the pulmonary 
system and subsequently inhibits the phagocytic activity. Whether 
this inhibition is due to impaired enzymatic activity produced by lead 
as suggested by Kaminski (28) or whether lead produces a proliferation 
of immature phagocytes as Bouley (7) suggests has not been determined. 
Although a large quantity of lead enters the hematopoietic system with 
inhalation, at the concentration used it is evident that lead does not 
reach the peritoneal Mf or that these phagocytes are less sensitive to 
the cytotoxic effect of lead. 
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2.2 LD5o Determination 
Decreased immunologic reactivity at both the humoral and cel-
lular levels has been shown to occur with lead exposure. To determine 
whether acquired immunity is impaired in ~ following lead exposure 
as reported by Hoffman (26), Hemphill (25) and Selye (52), 
LD50 determinations using Salmonella typhimurium were performed. 
Results for the LD5o obtained for group Pboral were similar to 
those obtained for controls Coral• This finding correlates with pre-
vious results for this group. Dysfunction of the immune system was 
not evident in this group suggesting lead ingested at the quantity 
used in this group was rapidly excreted and eliminated. 
Inhalation of lead resulted in very large differences in the LD5o 
value. A 128-fold decrease in LD5o titer occurred in group Phair~ 
Possible factors responsible for this decrease are the following: 
1) antibody levels were reduced; 2) phagocytic activity of specific M~ 
was inhited; 3) complement activity was reduced; or 4) liver enzyme 
function was impaired resulting in decreased endotoxin neutralization 
(16,26). All of the previously mentioned factors alone or together 
can easily account for the increased mortality seen in the lead aero-
solized group. These results further demonstrate our observations 
that inhaled lead poses a greater health hazard than previously 
determined 
2.3 Lead Concentration in Tissues 
A rapid elimination of lead occurs after ingestion, as is 
evident from ato~c absorption spectrums obtained from various tissue 
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samples. Only the kidney had elevated (p < 0.05) lead levels in group 
Pb0 ral compared with controls. This is not an unusual finding; Koller 
et al. (33) reported elevated kidney lead levels in mice administered 
lead orally. It is interesting to note that no impairment was ob-
served for any of the parameters measured in this group; in addition, 
lead levels in blood, serum, liver, lung, spleen and thymus all ~ re 
of a normal level, again indicating rapid elimination of ingested 
lead. 
Inhalation of lead resulted in elevated lead tissue levels in all 
organs with the exception of the blood and spleen. This is unusual 
because antibody formation (due to B-lymphocytes found in the spleen) 
was decreased. The findings that lead levels in the spleen were nor-
mal and normal peritoneal M~ function was observed suggest that cir-
culating lead may not reach this area to any great extent. If this is 
the case, the B-lymphocyte may not be responsible for the reduction in 
antibody to srbc and Salaonella typhimurium. The T-lymphocyte may be 
the predominant cell type affected by lead. These data also indicate 
the need for improved monitoring of lead levels other than blood 
levels, since these were found to be comparable to controls. Similar 
findings were reported by Schlick (48) who reported normal blood lead 
levels in exposed animals. Since serum lead levels were found to be 
greatly elevated (10%) in the aerosolized lead group, monitoring of 
sera rather than whole blood may prove a more sensitive indicator of 
lead exposure. 
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Summary 
At the subclinical dose of lead administered in this investigation 
it has become apparent that the route of exposure plays a critical 
role in the imrnunotoxic effects produced by this element. Ingested 
lead resulted in little or no adverse immunotoxic effects. The same 
quantity of lead, when inhaled resulted in suppression of both ce~l 
mediated and humoral immune responses. Observed cellular effects 
included a reduction of monocytes, decreased phagocytic activity of 
alveolar macrophage and decreases in neutrophils leading to an 
increase in the lymphocyte population. Humoral suppressive effects 
seen were decreased antibody levels, increased susceptibility to bac-
terial infection, lowered antibody titers to T and B cell immunogen 
and decreased hemolytic complement activity, both in vivo and 
in vitro. Other observed effects included elevated lead levels in 
liver, lung, spleen, thymus and serum. These changes all occurred 
without indication of anemia (normal hematocrit), suggesting subclini-
cal exposure to lead. 
It was also observed that blood lead levels (clotted blood) were 
not elevated from any of the exposed groups using atomic absorption 
spectrophotometry. Si~lar results have previously been reported 
(48). This finding further demonstrates the need for a more sensitive 
method for determining exposure to lead compounds. 
With the results reported in this study it has been demonstrated 
that lead exposure poses a significant health hazard which could lead 
to lowered ability to resist infection, as well as lower the immuno-
surveillance mechanism thereby increasing the chance of neoplasia. 
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Appendix 
Trypan Blue Dye Solution (Stock) 
A. Trypan Blue 
Distilled Water 
1 g 
100 ml 
(Working) 
Trypan Blue (Stock) 1 ml 
Isotonic Saline 9 ~1 
B. Bouins Fixative 
Picric Acid, saturated aqueous 
Formalin 
Glacial acetic acid 
75 ml 
25 ml 
5 ml 
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